Ivermectin for preventing and treating COVID‐19
M Popp, M Stegemann, MI Metzendorf… - Cochrane Database …, 2021 - cochranelibrary.com
Background Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the
replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of …
replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of …
Small molecules in the treatment of COVID-19
S Lei, X Chen, J Wu, X Duan, K Men - Signal transduction and targeted …, 2022 - nature.com
The outbreak of COVID-19 has become a global crisis, and brought severe disruptions to
societies and economies. Until now, effective therapeutics against COVID-19 are in high …
societies and economies. Until now, effective therapeutics against COVID-19 are in high …
Infectious Diseases Society of America Guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19)
Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …
Effect of ivermectin vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial
Importance The effectiveness of ivermectin to shorten symptom duration or prevent
hospitalization among outpatients in the US with mild to moderate symptomatic COVID-19 is …
hospitalization among outpatients in the US with mild to moderate symptomatic COVID-19 is …
[图书][B] The economics of health and health care
The Economics of Health and Health Care is the market-leading health economics textbook,
providing comprehensive coverage of all the key topics, and balancing economic theory …
providing comprehensive coverage of all the key topics, and balancing economic theory …
Epigallocatechin gallate as a nutraceutical to potentially target the metabolic syndrome: Novel insights into therapeutic effects beyond its antioxidant and anti …
Y Ntamo, B Jack, K Ziqubu… - Critical Reviews in …, 2024 - Taylor & Francis
Epigallocatechin gallate (EGCG) is one of the most abundant and powerful flavonoids
contained in green tea. Because of the global increase in green tea consumption, there has …
contained in green tea. Because of the global increase in green tea consumption, there has …
Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype
MS Marcolino, KC Meira, NS Guimarães… - BMC Infectious …, 2022 - Springer
Background The role of ivermectin in the treatment of COVID-19 is still under debate, yet the
drug has been widely used in some parts of the world, as shown by impressive market data …
drug has been widely used in some parts of the world, as shown by impressive market data …
Infectious diseases society of america guidelines on the treatment and management of patients with COVID-19 (september 2022)
There are many pharmacologic therapies that are being used or considered for treatment of
coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence …
coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence …
Changes in SpO2 on room air for 34 severe COVID-19 patients after ivermectin-based combination treatment: 62% normalization within 24 hours
JC Stone, P Ndarukwa, DE Scheim, BM Dancis… - Biologics, 2022 - mdpi.com
The emergence of COVID-19 in March 2020 challenged Zimbabwe to respond with limited
medical facilities and therapeutic options. Based on early clinical indications of efficacy for …
medical facilities and therapeutic options. Based on early clinical indications of efficacy for …
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities
R Kumar, Ö Aktay-Cetin, V Craddock… - PLoS …, 2023 - journals.plos.org
The Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) and its sublineages pose a new challenge to healthcare …
Coronavirus 2 (SARS-CoV-2) and its sublineages pose a new challenge to healthcare …